On January 25, 2022 Sigyn Therapeutics, Inc. (OTC Markets:"SIGY"), a medical technology company focused on the treatment of pathogen-related conditions that precipitate sepsis, reported that its Chairman and CEO, Jim Joyce, will give a corporate presentation at the upcoming Bullseye Small Cap Virtual Investor Conference to be held on January 27th and 28th, 2022 (Press release, Sigyn Therapeutics, JAN 25, 2022, View Source [SID1234607420]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mr. Joyce’s presentation is scheduled to begin at 3:30 pm eastern on January 27th, 2022. To virtually attend, register at:
Sigyn management will also be available for online 1×1 meetings with the members of the investment community. To schedule a meeting please visit: View Source or email [email protected].
Mr. Joyce’s presentation will include an update on Sigyn Therapy, a multi-function blood purification technology being advanced to treat a broad-spectrum of pathogen related conditions that precipitate sepsis.
Additional information on Sigyn Therapy, including recent media coverage, can be accessed through the links below:
January 11, 2022 – "Sigyn Therapeutics: Calming and Preventing the Cytokine Storm"
January 17, 2022 – "A Perfect Storm of Superbugs"
January 20, 2022 – "How COVID-19 Has Spurred a Shift to Broad-Spectrum Countermeasures Against Viruses"